Hekimsoy, T. Et Al. 2018. Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor. 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Düsseldorf, Germany).

Hekimsoy, T., Isgoren, S., Gorur, G. D., & Demir, H., (2018). Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor . 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany

Hekimsoy, T. Et Al. "Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor," 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 2018

Hekimsoy, T. Et Al. "Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany, 2018

Hekimsoy, T. Et Al. (2018) . "Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany.

@conferencepaper{conferencepaper, author={T. Hekimsoy Et Al. }, title={Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor}, congress name={31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Düsseldorf}, country={Germany}, year={2018}}